(ABEO) |
0 (0%) 10-09 22:52 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 7.00 |
Resistance 1: | 6.30 |
Pivot price: | 5.41 |
Support 1: | 5.18 |
Support 2: | 4.31 |
52w High: | |
52w Low: |
EPS | -33520000.000 |
Book Value | 0.640 |
PEG Ratio | 0.00 |
Gross Profit | -0.725 |
Profit Margin (%) | 14.00 |
Operating Margin (%) | 310.50 |
Return on Assets (ttm) | -5.0 |
Return on Equity (ttm) | 698.0 |
Thu, 09 Oct 2025
ABEO MXV Shift Walking Shoes for Women | Plantar Fasciitis Relief | Orthopedic Shoes for Women | Removable Orthotic Inserts - The San Joaquin Valley Sun
Thu, 09 Oct 2025
ABEO Jumpstreet Sneakers for Women | Arch Support Sneakers | Comfortable Women's Sneakers | Fashion Sneakers | Built-in Orthotic Insole - The San Joaquin Valley Sun
Thu, 09 Oct 2025
ABEO Men's Galaxy Metatarsal Active Recovery Sandal, Post Run & Exercise Sport Thong Sandals With High Arch Support For Metatarsalgia Relief - Sandals - The San Joaquin Valley Sun
Thu, 09 Oct 2025
ABEO Oasis Thong Sandals For Women | Arch Support Sandals | Built-In Orthotic Insole | Plantar Fasciitis Pain Relief - The San Joaquin Valley Sun
Wed, 08 Oct 2025
Abeona Therapeutics (ABEO) Expands Treatment Options for RDEB Pa - GuruFocus
Wed, 08 Oct 2025
Children's Hospital Colorado named newest QTC for Abeona's FDA‑approved ZEVASKYN to treat RDEB - Stock Titan
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |